Ovariectomy drives increase of an ECM transcription signature in the posterior eye and retina

• Published in: Vision research (Oxford) 2024-12, Vol.225, p.108507, Article 108507
• Main Authors: Wong, Cydney A., Sanchez-Rodriguez, Gabriela, Ethier, C. Ross, Wood, Levi B., Feola, Andrew J.
• Format: Article
• Language: English
• Subjects: Aging; Aging - physiology; Animals; Extracellular Matrix - metabolism; Female; Gene Expression Regulation - physiology; Glaucoma; Glaucoma - genetics; Glaucoma - metabolism; Glaucoma - physiopathology; Menopause; Optic Disk - metabolism; Ovariectomy; Rats; Rats, Long-Evans; Retina - metabolism; RNA sequencing
• ISSN: 0042-6989; 1878-5646; 1878-5646
• DOI: 10.1016/j.visres.2024.108507

Increased risk of developing glaucoma has recently been associated with early age of menopause. Here, we examined how age and surgically-induced menopause via ovariectomy (OVX) impacted gene expression in gene pathways previously linked to glaucoma, such as extracellular matrix (ECM) remodeling and TGF-β signaling. Using bulk RNA sequencing, we analyzed changes in young (3–4 months) and middle-aged (9–10 months) Long-Evans rats. We focused on posterior pole tissues (sclera and optic nerve head) but also examined the retina to compare observed changes across different tissue regions. Our results demonstrated that aging and OVX significantly alter gene expression in the sclera and optic nerve head. Generally, OVX triggered the enrichment of immune-related processes. However, OVX in young rats also led to significant enrichment of ECM and TGF-β gene sets. At the same time, these effects were diminished in middle-aged rats, indicating an age dependency of the effects of OVX on matrix-related pathways. Notably, the transcriptional factor Fos was downregulated in the posterior eye and retina in aged and OVX animals. Fos is a major regulator of cell proliferation and survival, and its dysregulation may play an important role in aging and menopause for women. These findings underscore the important role of menopause timing in modulating molecular pathways associated with glaucoma, which is consistent with clinical studies showing that early menopause may heighten the risk of developing this condition. This study also highlights the importance of considering women’s health factors, such as menopause, in understanding and managing glaucoma risk.